Please login to the form below

Not currently logged in
Email:
Password:

tiotropium bromide

This page shows the latest tiotropium bromide news and features for those working in and with pharma, biotech and healthcare.

Boehringer starts to feel impact of Spiriva generics

Boehringer starts to feel impact of Spiriva generics

The privately-held German pharma company said this morning that sales of Spiriva (tiotropium bromide) declined 16% to 1.45bn in the first six months of the year thanks to the ... combination therapy Spiolto/Stiolto (tiotropium plus olodaterol).

Latest news

  • Forest Labs launches COPD drug Tudorza in US

    Tudorza (aclidinium bromide) is a long-acting muscarinic antagonist (LAMA) originally developed by Spain's Almirall and is already on the market in Germany, the UK and Denmark, where it is ... It is however likely to see stiff competition from other

  • Breathing easier

    While there are several therapies currently in late-stage clinical trials for COPD — including aclidinium bromide (Eklira, Almirall Prodesfarma/Forest Laboratories), vilanterol/fluticasone furoate (Relovair, GSK), andolast (Rottapharm Madaus) and

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics